Akers Biosciences Cm (AKER) 2.10 $AKER Akers Biosciences

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 3:23 AM

Akers Biosciences Cm (AKER) 2.10 $AKER

Akers Biosciences to Present at LD Micro Invitational Conference
Marketwire Canada - Fri Jun 03, 8:52AM CDT
THOROFARE, NJ--(Marketwired - Jun 3, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) (the "Company"

, a developer of rapid health information technologies, announces that Co-founder and Chief Scientific Director, Raymond F. Akers, Jr. PhD, will present to investors attending the upcoming LD Micro Invitational Conference in Los Angeles, CA. on Tuesday June 7, 2016. Dr. Akers intends to provide an update on the Company's business including the increasing traction in the US and China of the Company's flagship rapid test for Heparin-induced thrombocytopenia.
AKER: 2.10 (-0.03)

Akers (AKER) Reports Q1 Earnings; Product Revenue Up 79.3%
Aparajita Dutta - Zacks Investment Research - Thu May 12, 7:46AM CDT
Akers' (AKER) first-quarter product revenue increased 79.3% from the year-ago quarter to $738,023
AKER: 2.10 (-0.03)

Akers Biosciences Reports Earnings for Q1 2016
Marketwire Canada - Thu May 12, 6:00AM CDT
PIFA Heparin/PF4 Rapid Tests Sales Up 88%; Total Revenues up 45%
AKER: 2.10 (-0.03), AKR: 34.18 (-0.05)

Akers Biosciences Announces Conference Call to Discuss Q1 2016 Earnings
Marketwired - Tue May 10, 6:00AM CDT
THOROFARE, NJ--(Marketwired - May 10, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, will hold a conference call on Thursday, May 12, 2016 at 09:00 a.m. Eastern Time to discuss its earnings for the first quarter ended March 31, 2016, which will be published earlier that day. Management will be available during a question-and-answer session.
AKER: 2.10 (-0.03)

Akers Biosciences (AKER) Q1 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:52AM CDT
Akers Biosciences Inc (AKER) is expected to report first-quarter 2016 results on May 12.
CAPR: 4.27 (-0.05), STAA: 5.26 (-0.15), AKER: 2.10 (-0.03), VBLT: 3.96 (-0.03)

Akers Biosciences to Present at 'Pioneers 2016' Investor Conference
Marketwire Canada - Wed May 04, 1:00PM CDT
THOROFARE, NJ--(Marketwired - May 4, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company"

, a developer of rapid health information technologies, is presenting at Joseph Gunnar & Co., LLC's 'Pioneers 2016' conference in New York on May 5, 2016.
AKER: 2.10 (-0.03), AKR: 34.18 (-0.05)

Akers Board Rearrangement
Marketwired - Fri Apr 29, 6:01AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, announces changes to the roles of certain board members, which take effect immediately and are designed to improve the effectiveness of the Board of Directors.
AKER: 2.10 (-0.03)

Akers' Loss Widens in 2015, Revenues Deteriorate Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 9:46AM CDT
Akers Biosciences Inc. (AKER) reported loss of $1.81 per share in full-year 2015, much wider than 66 cents recorded in 2014.
AMZN: 710.60 (-5.22), BAX: 44.94 (-0.07), AKER: 2.10 (-0.03), HRC: 51.28 (+0.16)

Akers Biosciences Reports Earnings for Fiscal Year 2015
Marketwired - Wed Mar 30, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, reports its financial results for the fiscal year ended December 31, 2015.
AKER: 2.10 (-0.03)

What Awaits Akers Biosciences (AKER) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 8:10AM CDT
Akers Biosciences Inc (AKER) is expected to report fourth-quarter 2015 earnings results on Mar 30.
AMZN: 710.60 (-5.22), AXDX: 15.29 (-0.09), AKER: 2.10 (-0.03)

Akers Biosciences' Protein Preparation Gets Patent Cover
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 9:10AM CDT
Akers Biosciences Inc. (AKER) recently won a patent from the United States Patent and Trademark Office (USPTO) for its proprietary protein preparation.
BAX: 44.94 (-0.07), LMAT: 14.69 (+0.15), AKER: 2.10 (-0.03), HRC: 51.28 (+0.16)

Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection
Marketwired - Wed Mar 23, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, announces that the United States Patent and Trademark Office has allowed a patent covering Akers Bio's proprietary methods for detecting heparin/platelet factor 4 antibodies (the "Patent"

.
AKER: 2.10 (-0.03)

Akers Biosciences Announces Conference Call to Discuss Its 2015 Earnings
Marketwired - Wed Mar 16, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company"

, a developer of health information technologies, will hold a conference call on Wednesday, March 30, 2016 at 09:00 a.m. Eastern Time to discuss its earnings, which will be published earlier that day, for the fiscal year ended December 31, 2015.
AKER: 2.10 (-0.03)

Akers Receives Order for Rapid Assays in China; Shares Rise
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 1:20PM CST
Shares of Akers Biosciences (AKER) rallied 11.2% (19 cents) on Mar 2, following the announcement of an order to supply PIFA Heparin PF4/Rapid Assay products in China.
ABMD: 101.70 (-0.06), AKER: 2.10 (-0.03), LMNX: 19.69 (-0.03), CRY: 11.85 (-0.15)

Akers Biosciences to Present at Disruptive Growth & Healthcare Conference
GlobeNewswire - Mon Feb 08, 11:18AM CST
Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"

, a developer of cutting edge technologies that deliver rapid health information, is presenting at Source Capital's 2016 Disruptive Growth & Healthcare conference in New York on February 10, 2016.
AKER: 2.10 (-0.03)

Akers Biosciences JV Facility Now Operational in China
Zacks Equity Research - Zacks Investment Research - Thu Dec 03, 11:50AM CST
Akers Biosciences (AKER) recently announced that its Chinese joint venture's 10000 square foot production facility is now fully operational.
ICUI: 104.98 (+0.28), AMZN: 710.60 (-5.22), NXTM: 19.38 (-0.54), AKER: 2.10 (-0.03)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Metriport Eyes Major Step in Health Data Integration

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Foodcare Proves Effective in Reducing Blood Sugar Levels

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Chad Tucker's Sequel Explores Deep Spiritual Themes

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

EnGenius Names Experienced VP to Boost Sales Growth

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Andover Audio's FreePlay: Stereo Sound Goes Portable

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Piedmont Orthopedics Expands Care in Henry County

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

WareSpace Expands Reach With $36.5M Acquisitions

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

EmpowHer Grants Propel Female-led Social Ventures Forward

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...